Panacea Biotec Limited (NSE: PANACEABIO), ISIN INE922B01023 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
PANACEABIO last traded at ₹415.15 (-2.13%), with a 52-week range of ₹293.10 to ₹647.50 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 72.48%, FIIs 2.31%, DIIs 2.25%, mutual funds 0.00%.
EquiSense Score (ECS): 61/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.